Pesquisas alternativas:
complex cases » complex causes (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
land company » lncd company (Expandir a Pesquisa), bad company (Expandir a Pesquisa), can company (Expandir a Pesquisa)
company carl » company car (Expandir a Pesquisa), company cars (Expandir a Pesquisa), company carlos (Expandir a Pesquisa)
scl complex » cl complex (Expandir a Pesquisa), nacl complex (Expandir a Pesquisa), msl complex (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
com can » com cana (Expandir a Pesquisa), com cant (Expandir a Pesquisa), com cal (Expandir a Pesquisa)
3 land » 3 lan (Expandir a Pesquisa), 3 ligand (Expandir a Pesquisa)
l com » l como (Expandir a Pesquisa), e com (Expandir a Pesquisa), l con (Expandir a Pesquisa)
_ scl » _ scf (Expandir a Pesquisa), _ sci (Expandir a Pesquisa), _ sch (Expandir a Pesquisa)
complex cases » complex causes (Expandir a Pesquisa), complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa)
land company » lncd company (Expandir a Pesquisa), bad company (Expandir a Pesquisa), can company (Expandir a Pesquisa)
company carl » company car (Expandir a Pesquisa), company cars (Expandir a Pesquisa), company carlos (Expandir a Pesquisa)
scl complex » cl complex (Expandir a Pesquisa), nacl complex (Expandir a Pesquisa), msl complex (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
com can » com cana (Expandir a Pesquisa), com cant (Expandir a Pesquisa), com cal (Expandir a Pesquisa)
3 land » 3 lan (Expandir a Pesquisa), 3 ligand (Expandir a Pesquisa)
l com » l como (Expandir a Pesquisa), e com (Expandir a Pesquisa), l con (Expandir a Pesquisa)
_ scl » _ scf (Expandir a Pesquisa), _ sci (Expandir a Pesquisa), _ sch (Expandir a Pesquisa)
1
Por van der Feltz-Cornelis, Christina M, Meeuwissen, Jolanda AC, de Jong, Fransina J, Hoedeman, Rob, Elfeddali, Iman
Publicado em 2007
“... in diagnosis and treatment, and seem to be in need of support for a new approach to handle cases of more...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Publicado no Cell Prolif
(2002)
“...) and SPF (r = 0.77). P53 immunoreactivity was present in 71.4% of the tumours, whereas 39.3% of cases were...”Obter o texto integral
Obter o texto integral
Artigo